Uric acid and renal function in Multiple Sclerosis

Clinica Terapeutica

Volumn 159, Issue 1, 2008, Pages 35-40

  Kanabrocki, Eugene L ^a   Ryan, M D ^a   Hermida, R C ^c   Ayala, D E ^c   McCormick, J B ^b   Dawson, S ^b   Lojo, L ^a   Hoffman, H S ^a   Siegel, G ^a   Friedman, N ^a   Eladasori, B ^a   Parachuri, R ^a   Nemchausky, B A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SWEDISH COVENANT HOSPITAL   (United States)

^c UNIVERSITY OF VIGO   (Spain)

Author keywords

Circadian; Creatinine and uric acid clearance; MS; Renal dysfunction

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; CREATININE; ELECTROLYTE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; NITRIC OXIDE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; FEMALE; HUMAN; INSULIN SYNTHESIS; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LYMPHOCYTE; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PROTEIN DETERMINATION; SEX DIFFERENCE; URIC ACID CLEARANCE; URINALYSIS;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CREATININE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEX DISTRIBUTION; URIC ACID; VIRGINIA;

EID: 40549128683     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Simpson HW, Bohlen JG. Latitude and the human circadian system. In: Mills JN, (Ed). Biological Aspects of Circadian Rhythms. Plenum Press, London, 1973; 85-120
2. Ghatta J, Reiberg A, Lagoguey M, et al. Human circadian rhythms documented in may-june from three groups of young men living respectively in Paris, Columbo and Sidney. Chronobiologia 1977; 4:181-90
3. Reder AT, Makowiec RL, Lowy MT. Adrenal size is increased in multiple sclerosis. Arch Neurol 1994; 51(2):151-4
4. Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47:51-9
5. Fang J, Alderman MH. Serum Uric acid and cardiovascular mortality. The NHANES 1 Epidemiological Followup Study, 1971-1992. JAMA 2000; 283:2404-10
6. Rich MW. Uric Acid: Is it a risk factor for cardiovascular disease? Am J Cardiol 2000; 85:1018-21
7. Chonchol M, Shlipak MG, Katz R, et al. relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007; 50(2):239-47
8. Hooper DC, Spitsin SV, Kean RB, et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Nat Acad Sci USA 1998; 95:675-80
9. Sotgiu S, Pugliasti M, Sanna A, et al. Serum uric acid and multiple Sclerosis. Neurol Sci 2002; 23:183-8
10. Toncev G, Milicic B, Toncev S, et al. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood barrier dysfunction. Eur J Neurol 2002; 9(3):221-6
11. Spitsin S, Hooper DC, Mikheeva T, et al. Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Multiple Sclerosis 2001; 7:165-6
12. Drulovic J, Dujmovic I, Stojsavljevic N, et al. Uric acid levels in sera from patients with multiple sclerosis. J Neurol 2001; 248:121-6
13. Smith MA, Richey K, Harris PL, et al. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17:2653-7
14. Kasa M, Bierma TJ, Waterstraat F Jr. Routine blood chemistry screen: A diagnostic aid for Alzheimer's disease. Neuroepidemiol 1989; 8:254-61
15. Davis JW, Graandinette A, Waslien CI, et al. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol 1996; 144(5):480-4
16. Kanabrocki EL, McCormick JB, Hermida RC, et al. Circadian interrelationship between serum uric acid and nitric oxide in adult male subjects. JAMA 2000; 283:2230-41
17. Kanabrocki EL, Hermida RC, Right M, et al. Circadian variation of serum leptin in healthy and diabetic men. Chronob Int 2001; 118(2):273-83
18. Kanabrocki EL, George M, Hermida RC, et al. Day-night variations in blood levels of Nitric Oxide, T-TFPI, and E-Selectin. Clin Appl Thrombosis/Hemostasis 2001; 7(4):339-45
19. Cugini P, Manconi R, Serdoz R, et al. Rhythm characteristics of plasma renin, aldosterone and cortisol in five subtypes of mesor hypertension. J.Endocrinol Invest 1980; 3:143-7
20. Diem K. Scientific Tables. Documenta Geigy, Ardsley, New York, 1962; 528
21. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney dsease in a community-based population. A 10-year follow-up study. Kidney Int 2007; 71:159-66
22. Spitsin S, Hooper DC, Leist T, et al. Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approached to therapy of the disease. Multiple Sclerosis 2001; 7:313-9
23. Koprowski,H, Spitsin, SV, Hopper DC. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol 2001; 49:(1):139